1. NEBIVOLOL AND IRBESARTAN REDUCE POST-HEMODIALYSIS AND AMBULATORY BP IN PATIENTS WITH INTRADIALYTIC HYPERTENSION: A RANDOMIZED CROSS-OVER STUDY. (June 2018) Authors: Bikos, A.; Loutradis, C.; Aggeloudi, E.; Karpetas, A.; Raptis, V.; Ginikopoulou, E.; Panagoutsos, S.; Pasadakis, P.; Balaskas, I.; Liakopoulos, V.; Papagianni, A.; Sarafidis, P.A. Journal: Journal of hypertension Issue: Volume 36(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THE EFFECTS OF NEBIVOLOL AND IRBESARTAN ON CENTRAL BLOOD PRESSURE AND ARTERIAL STIFFNESS PARAMETERS IN HEMODIALYSIS PATIENTS WITH INTRADIALYTIC HYPERTENSION. (June 2018) Authors: Bikos, A.; Loutradis, C.; Aggeloudi, E.; Karpetas, A.; Raptis, V.; Alexiadis, J.; Balaskas, I.; Liakopoulos, V.; Papagianni, A.; Sarafidis, P.A. Journal: Journal of hypertension Issue: Volume 36(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗